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Abstract: Chondroitin sulfate A was covalently immobilized onto a monolithic silica epoxy column 
involving a Schiff base formation in the presence of ethylenediamine as a spacer and evaluated in 
terms of its selectivity in enantioseparation. The obtained column was utilized as a chiral stationary 
phase in enantioseparation of amlodipine and verapamil using a mobile phase consisting of 50 mM 
phosphate buffer pH 3.5 and UV detection. Sample dilution by organic solvents (preferably 25% v/v 
acetonitrile-aqueous solution) was applied to achieve baseline enantioresolution (Rs > 3.0) of the 
individual drug models within 7 min, an excellent linearity (R2 = 0.999) and an interday repeatability 
of 1.1% to 1.8% RSD. The performance of the immobilized column for quantification of racemate in 
commercial tablets showed a recovery of 86–98% from tablet matrices. Computational modeling by 
molecular docking was employed to investigate the feasible complexes between enantiomers and 
the chiral selector. 
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1. Introduction 
Polysaccharide-based chiral stationary phases (CSPs) play an important role in en-
antioseparations of chiral compounds by high-performance liquid chromatography 
(HPLC) [1]. Due to the asymmetric and long-range helical structures, polysaccharides of-
fer high recognition capacity and enantioselectivity toward broad types of chiral sub-
stances [2,3]. As one of the most prominent separation methods in analysis and prepara-
tive purposes, HPLC using amylose-based and cellulose-based columns delivers excellent 
performance [4–7]. In the beginning, the utilization of polysaccharide-based CSPs faced a 
restriction in the enantioselectivity improvement due to their low compatibility toward 
polar organic modifiers [8,9]. Therefore, immobilized CSPs are developed to achieve an 
expansion of column compatibility with a wide range of solvent polarity [9,10]. Immobi-
lized CSPs typically could be applied in normal phase (NP)-, reversed-phase (RP)-, and 
polar-elution mode with a large diversity of organic solvents as mobile phases [1,11]. On 
the other hand, coated CSPs can only be used as a single mode in NP or RP. 
Immobilization of a chiral selector onto macroporous silica has been conducted 
through a radical copolymerization reaction [12] and a photochemical technique [9]. In 
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